NewsClick

NewsClick
  • हिन्दी
  • Politics
  • Economy
  • Covid-19
  • Science
  • Culture
  • India
  • International
  • Sports
  • Articles
  • Videos
search
menu

SUBSCRIBE AND SUPPORT

image/svg+xml
  • All Articles
  • Newsclick Articles
  • All Videos
  • Newsclick Videos
  • हिन्दी
  • Politics
  • Economy
  • Science
  • Culture
  • India
  • Sports
  • International
  • Africa
  • Latin America
  • Palestine
  • Nepal
  • Pakistan
  • Sri Lanka
  • US
  • West Asia
About us
Grievance Redressal Mechanism
Newsletter
Facebook - Newsclick Twitter - Newsclick Instagram - Newsclick Youtube - Newsclick RSS - Newsclick
close menu
  • Politics
  • Economy
  • Science
  • Culture
  • India
  • International
  • Sports
×
You deserve independent, critical media. Subscribe and Support

Patents : All

Primary tabs

  • All(active tab)
  • Articles
  • Videos
  • Interviews
  • Make WHO-Recommended New COVID-19 Drugs Accessible, Affordable: MSF
    Richa Chintan
    Make WHO-Recommended New COVID-19 Drugs Accessible, Affordable: MSF
    15 Jan 2022
    US pharma giant Eli Lilly has the patent for Baricitinib, which will affect its availability and accessibility.
  • Vaccine Covid 19
    Arun Mitra
    Patent Rights on Medicines and Vaccines Must be Waived Off and Public Sector Pharma Companies Revived
    06 Jun 2021
    Patent rights on vaccines and medicines have to be waived off to save and promote global especially during such a pandemic, writes Dr. ARUN MITRA.
  • Vaccine Policy Modi
    Sonali Kolhatkar
    Why Big Pharma’s Arguments Against Patent Waivers Don’t Add Up
    20 May 2021
    While President Biden is backing the temporary lifting of COVID-19 vaccine patents, drugmakers are making dire predictions of stifled innovation and eroded public trust. What they really fear is…
  • Patent and Patient Rights in COVID-19: Is the Right to Exclusivity a Hamlet Question?
    Justice Prabha Sridevan
    Patent and Patient Rights in COVID-19: Is the Right to Exclusivity a Hamlet Question?
    09 Oct 2020
    Today the judicial authority may be faced with balancing patent rights and patients’ rights or right to life.
  • More Than 75% Patents Filed in India Over 13 Years by Foreign Nationals and Companies
    Newsclick Report
    More Than 75% Patents Filed in India Over 13 Years by Foreign Nationals and Companies
    10 Sep 2020
    Of the total 5.1 lakh applications, nearly 1.4 lakh patent applications were from the US alone. The country accounted for about 27% of all applications over the 13-year period.
  • Prabir Purkayastha
    Break Gilead’s Patent Since US has Bought all Stock of Remdesivir
    02 Jul 2020
    Trump is trying to improve his waning electoral chances by reserving all of Gilead’s stock of Remdesivir to cover up his disastrous handling of the Covid-19 epidemic so far.
  • A Lot Can Still be Done
    Bharat Dogra
    A Lot Can Still be Done to Lessen COVID-19 Damage
    06 Apr 2020
    The pandemic and the resulting lockdown have come at a time when the rabi harvest is due in most parts of India.
  • India Has Fewer Researchers Than China and South Korea, Says Report
    Newsclick Report
    India Has Fewer Researchers Than China and South Korea, Says Report
    29 Nov 2019
    According to the report, India is falling way behind other countries in terms of funds devoted to research and development.
  • Dr. Amit Sengupta01.png
    Newsclick Production
    Compulsory License for Medicines: Government Protecting the Interest of India or the US?
    28 Mar 2016
    In order to ensure that drug companies cannot play with the lives of patients (for instance by either stopping the sale of a drug or making it incredibly expensive) - the Indian Patents Act…
  • Patents.jpeg
    Author
    India-US Joint Working Group on IPR
    05 Nov 2014
    21 October 2014
  • Load More
Newsletter
About us
Grievance Redressal Mechanism